Maimonides Institute of Biomedical Research of Cordoba

Information

Alzheimer's, cancer, covid-19, diabetes, cardiovascular diseases, neurodegenerative diseases, rare diseases, ageing, immunology, AIDS / HIV

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Pediatrician at the Pediatric Endocrinology Unit of the Reina Sofia University Hospital of Cordoba, belonging to the group GC23 Children's Metabolism of the Maimonides Institute of Biomedical Research of Cordoba, and associate professor at the University of Cordoba

Professor of Cell Biology in the Department of Cell Biology, Physiology and Immunology at the University of Cordoba and researcher in charge of the Hormones and Cancer group at the Maimonides Institute of Biomedical Research of Cordoba (IMIBIC)

Contents related to this centre
Splicing

A team of researchers led by the Center for Genomic Regulation in Barcelona has mapped the human spliceosome for the first time. This complex and partially unknown cellular machinery is responsible for cutting and splicing the RNA fragments encoded by genes in different ways, making it possible to obtain a wide variety of proteins from the same sequence. Its alteration is related to processes such as cancer, neurodegenerative processes or various rare diseases. According to the researchers, who publish the results in the journal Science, “by knowing exactly what each part does, we can find completely new angles to address a broad spectrum of diseases”.

Liraglutida

A new study presented at the annual meeting of the European Association for the Study of Diabetes (EASD), being held in Madrid from September 9-13, and published simultaneously in the New England Journal of Medicine (NEJM), has revealed that liraglutide, an anti-obesity drug, is safe and effective in children aged 6-12 years.